CA Patent

CA983919A — Steroid compounds

Assigned to Glaxo Laboratories Ltd · Expires 1976-02-17 · 50y expired

What this patent protects

Patent listed against Agamree.

Drugs covered by this patent

Agamree (VAMOROLONE) · Catalyst Pharms

Patent Metadata

Patent number: CA983919A
Jurisdiction: CA
Classification: —
Expires: 1976-02-17
Drug substance claim: No
Drug product claim: No
Assignee: Glaxo Laboratories Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.